Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StrataGraft for Complex Skin Defects
NCT00618839Phase 2Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Jul 2006
- Primary completion
- Apr 2008
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen, sponsored by Mallinckrodt Pharmaceuticals. Primary endpoint: Percent Autograft Take on Wounds Prepared by StrataGraft™ Skin Tissue. Started Jul 2006; status: completed.
02
Drugs
allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen
Beyond the preview
Go deeper on NCT00618839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00618839.